◆ 会议时间：2023年9月13日至16日
◆ 会议地点：美国 新奥尔良

◆ 会议简介：

2023年第111届美国临床骨科学会(COS)年会将于2023年9月13日至16日在美国新奥尔良举行。
美国临床骨科学会(COS)成立于1912年。COS于每年秋季召开一次年度会议，骨科专家小组将探讨临床骨科的相关案例研究和创新技术。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

111th Annual Meeting of the Clinical Orthopaedic Society (COS)
Dates: September 13-16, 2023
Venue: The Westin New Orleans, New Orleans, LA, USA

摘要征文投稿：

Abstracts accepted through May 15, 2023

点此提交摘要>>>Submit Abstract>>>

Policies Governing Accepted Submissions:

1. Abstracts must be submitted online by May 15, 2023 to be eligible for review by the Program Committee.
2. Submission of a corrected abstract is not allowed after May 15, 2023.
3. Once an abstract is accepted, additional authors cannot be added.
4. An orthopaedic surgeon, resident and/or a member of COS must be listed as one of the authors.
5. Acceptance or rejection letters, and all future correspondence will be emailed to the Primary Contact listed on the Abstract Submission Form. Notification of acceptance will be sent in July 2023 to the email address provided on the submission form. Failure to complete Presenter Forms by the date listed, will result in the presentation being removed from the program.
6. Abstracts not accepted for a podium presentation may be accepted for an E-Poster presentation.
7. The paper is to be original, unpublished work.
8. All co-authors must complete a disclosure form, or your presentation will be eliminated from the meeting.
9. A copy of the manuscript may be requested for award consideration as determined by the Program Committee. The stipend for the award paper is contingent on the Resident/Fellow author, listed as the Primary Author on the Abstract Submission Form, presenting the paper at the Annual Meeting.
10. COS reserves the right to publish the accepted abstracts in a medical journal. This will not preclude publishing the manuscript in another journal.
11. The COS reserves the right to withdraw a presentation at any time.

Instructions to complete abstract submissions:

1. TITLE: Make the title brief and clearly indicate the nature of the study/procedure. Do not use all caps. Please do not use similar titles for numerous submissions.
2. CONTENT: The abstract must include four parts: INTRODUCTION should clearly state the problem and the purpose of the study; METHODS should provide a description of what was actually done; RESULTS should contain the findings of the study; DISCUSSION AND CONCLUSION should be based upon the findings and relate to the stated purpose of the study and existing knowledge. Provide specific details about your research/study. DO NOT list any author's name or institution in the abstract or manuscript. A two-year minimum follow-up per patient is required for all results for reconstructive procedures and new or modified techniques as they relate to diagnosis, surgery, complications or other phases of orthopaedic surgical problems.
3. LENGTH: The abstract should be typed on the form provided within space allotted (300 words max). Additional pages will not be accepted. Use English only.
4. STYLE: Use title case for the entire title: DO NOT include company names, titles, appointments or addresses in the abstract. DO NOT use subtitles. Standard abbreviations may be used, when necessary. Do not cite references. Omit P values. No reference is to be made in your text as to authors, institutions, clinics, pharmaceutical companies, or specific manufacturers. Submit the form, completed in full. Please check your work prior to submission. The Clinical Orthopaedic Society is not responsible for proofreading or accuracy.
5. DRUG NAMES: Nonproprietary (generic) names of drugs are required and should be written in lower case. Proprietary names are capitalized.
6. SUBMISSIONS: An Electronic Submission form is provided below for all submissions. The abstract submission deadline for COS' Annual Meeting is May 15, 2023.
7. NOTIFICATION OF ACCEPTANCE: The Program Committee will review Abstracts. You will be notified of acceptance by email by July 2023. The Clinical Orthopaedic Society reserves the right to withdraw a paper at any time.
8. REGISTRATION FEES: All presenters are required to register for the meeting and pay the registration fee.
9. MANUSCRIPT: The paper is to be original, unpublished work. Papers that have been previously published are ineligible. Papers that have been submitted for publication but will remain unpublished prior to the date of the Annual Meeting are eligible. If a paper is accepted but is subsequently found to have been published before the Annual Meeting, the Program Committee has the right to withdraw the paper.

Podium Presentation

Each Podium presentation will be approximately 4-6 minutes in length. Standard audiovisual equipment in the scientific session room includes an LCD projector and Windows Computer (not a Mac). Personal laptops cannot be used for presentations.

Resident/Fellow Awards

If your abstract has been identified by the Program Committee to be considered for an award, one copy of your full manuscript (without pictures, charts and graphs) may be requested after all the abstracts submitted are reviewed.

The COS will recognize outstanding papers submitted and presented by residents and fellows with the Resident/Fellow Paper Award, 3 Oral Abstract Awards and 3 Resident/Fellow Rapid Fire Awards. See policies and instructions above for additional information on award papers.

Grading Process

• Abstracts/Manuscripts will be read in a “blind” fashion. Your text should not reveal the authors or institutions of origin.
• Graders are orthopaedic surgeons and are members of the Program Committee. Each abstract is reviewed and graded by at least four individuals/orthopaedic surgeons and the final grade is then averaged.
• Grade is influenced by: significance of the study, content and clarity, specific number of cases or specimen studies, clinical or research data to support its conclusions, minimum follow-up of 2 years per patient for results describing reconstructive procedures, and new or modified techniques as they relate to diagnosis, surgery, complications or other phases of orthopaedic surgical problems.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。